Haw Par Corporation Limited (HAWPF)
OTCMKTS
· Delayed Price · Currency is USD
9.40
0.00 (0.00%)
May 27, 2025, 4:00 PM EDT
Haw Par Corporation Revenue
In the year 2024, Haw Par Corporation had annual revenue of 244.82M SGD with 5.50% growth. Haw Par Corporation had revenue of 126.70M in the half year ending December 31, 2024, with 46.37% growth.
Revenue
244.82M SGD
Revenue Growth
+5.50%
P/S Ratio
11.32
Revenue / Employee
411.47K SGD
Employees
595
Market Cap
2.03B USD
Revenue Chart
* This company reports financials in SGD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 244.82M | 12.76M | 5.50% |
Dec 31, 2023 | 232.06M | 49.97M | 27.44% |
Dec 31, 2022 | 182.09M | 40.91M | 28.98% |
Dec 31, 2021 | 141.18M | 30.15M | 27.15% |
Dec 31, 2020 | 111.03M | -132.96M | -54.49% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
American Oncology Network | 1.76B |